Literature DB >> 23531549

Short-term effects of proximal femoral derotation osteotomy on kinematics in ambulatory patients with spastic diplegia.

Dae Gyu Kwon1, Seung Yeol Lee, Tae Won Kim, Chin Youb Chung, Kyoung Min Lee, Ki Hyuk Sung, Bekhzad Akhmedov, In Ho Choi, Tae-Joon Cho, Won Joon Yoo, Moon Seok Park.   

Abstract

The aim of this retrospective study was to determine the short-term effects of proximal femoral derotation osteotomy (FDO) on gait in 53 ambulatory patients with spastic diplegia controlling all confounding procedures. All patients showed a jump gait pattern and had undergone bilateral rectus femoris transfer, distal hamstring lengthening, and tendo-Achilles lengthening as a single-event multilevel surgery. Of these, additional bilateral proximal FDOs were included in 25 patients, defined as the FDO group; the other 28 patients were defined as the no-FDO group. Kinematic variables, such as pelvic tilt, minimal hip flexion in stance, hip rotation, and foot progression angle, were compared between the two groups at postoperative 1 year. Hip extension, hip rotation, and hip adduction improved significantly after surgery in the FDO group (P<0.001, P=0.004, P=0.028), but not in the no-FDO group. Foot progression angle improved in both groups, but the degree of improvement was significantly greater in the FDO group (P=0.004). In conclusion, FDO improved hip rotation, hip adduction, and hip extension as well as foot progression angle in the ambulatory patients with spastic diplegia showing a jump gait.

Entities:  

Mesh:

Year:  2013        PMID: 23531549     DOI: 10.1097/BPB.0b013e32835f1f21

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  1 in total

1.  Femoral derotation osteotomy with multi-level soft tissue procedures in children with cerebral palsy: Does it improve gait quality?

Authors:  Yavuz Saglam; N Ekin Akalan; Yener Temelli; Shavkat Kuchimov
Journal:  J Child Orthop       Date:  2015-11-23       Impact factor: 1.548

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.